Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Grace Therapeutics, Inc GRCE

Healthcare
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

Recent & Breaking News (NDAQ:GRCE)

Acasti Pharma Reports Third Quarter 2017 Financial Results

MarketWire Canada January 12, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  December 23, 2016

Mid-Morning Market Update: Markets Edge Higher; Cal-Maine Sales Miss Estimates

Benzinga.com  December 23, 2016

Acasti Pharma Announces Proposed Offering of Units

MarketWire Canada December 5, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  November 29, 2016

Acasti Pharma Appoints Linda O'Keefe as Chief Financial Officer

MarketWire Canada November 28, 2016

Acasti Announces Stock Ticker Symbol Change to ACST on the TSXV

MarketWire Canada November 3, 2016

Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre

MarketWire Canada October 26, 2016

Acasti Pharma Reports Second Quarter 2017 Financial Results

MarketWire Canada October 11, 2016

15 Biggest Mid-Day Losers For Thursday

Benzinga.com  September 15, 2016

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  September 14, 2016

Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data

MarketWire Canada September 14, 2016

Acasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM

MarketWire Canada July 15, 2016

Acasti Announces First Quarter Results

MarketWire Canada July 11, 2016

Acasti Announces Grant of Stock Options

MarketWire Canada May 30, 2016

Acasti Announces Fourth Quarter and Fiscal Year Results

MarketWire Canada May 25, 2016

Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements

Marketwired March 25, 2016

Acasti Announces Management Appointment and Changes to the Board of Directors

Marketwired March 1, 2016

Acasti Announces Share-for-Debt

Marketwired February 5, 2016

Acasti Announces Third Quarter Results

GlobeNewswire January 12, 2016